Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 231 - 240 of 353

Selected Filters:
8 August 2022

Kenya National HIV & STI Combination Prevention Communication Strategy, 2019-24

The Kenyan Ministry of Health produced this communications strategy designed to enhance demand and uptake of a combination prevention based approach to HIV prevention.

Normative Guidance/Policies

Document
8 August 2022

Consolidated Guidelines on HIV, Viral Hepatitis and STI Prevention, Diagnosis, Treatment and Care for Key Populations (2022)

Released in July 2022, the consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for five key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings).…

Normative Guidance/Policies

Document
5 August 2022

WHO Guidelines on Long-Acting Injectable Cabotegravir for HIV Prevention

WHO guidelines, issued in 2022, recommend injectable cabotegravir (CAB) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. These guidelines provide considerations to support managers, policy makers, researchers, health workers, communities, and other stakeholders in the implementation of projects and programs for injectable CAB for PrEP. It…

Normative Guidance/Policies

Document
4 August 2022

HIV Prevention 2025 Roadmap

This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United Nations General Assembly adopted in June 2021 and they are underpinned by the Global AIDS Strategy (2021–2026). The…

Normative Guidance/Policies

Document
4 August 2022

Differentiated and Simplified Pre-exposure Prophylaxis for HIV Prevention: Update to WHO implementation guidance

This technical brief on implementation guidance for simplified and differentiated service delivery of PrEP supplements and updates the WHO Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring. The brief aims to support trends towards services becoming demedicalized, simplified, differentiated, digitalized, and integrated to increase uptake and effective use of PrEP.

Normative Guidance/Policies

Document
4 August 2022

WHO Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring

These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016.

Normative Guidance/Policies

Document
4 August 2022

Dual Prevention Pill Desk Review Insights

This desk review by M&C Saatchi collates existing data and insights related to uptake and adherence to HIV prevention, contraceptive, and multi-purpose technology pill products; confirms and identifies gaps in the existing knowledge base; and prompts discussions around key learning questions that need to be addressed to develop a robust and effective marketing and demand…

Demand Creation/Marketing

Document
4 August 2022

Review of Effective Marketing and Demand Creation Strategies in HIV Prevention and Family Planning that May Inform Demand-Side Thinking for the Dual Prevention Pill

This scoping review aims to document effective and sustainable demand creation strategies used in HIV prevention and Family Planning interventions, how they may be adapted for the Dual Prevention Pill (DPP), and explores what could be done differently for the DPP.

Demand Creation/Marketing

Document
4 August 2022

Generating Demand for HIV Biomedical Prevention in the Era of Choice

In light of the emerging need to (re-)define how to generate demand for choice in HIV biomedical prevention, AVAC, under BioPIC, convened program implementers; social and behavioural change communication, marketing, and design thinking experts; behavioral economists; researchers; donors; and civil society to identify proven and promising strategies and models to more effectively reach and engage…

Demand Creation/Marketing

Document
4 August 2022

Coordinating Implementation Science for CAB for PrEP

As implementation studies for injectable cabotegravir (CAB) for PrEP are being considered and as programs shift towards choice-based models for HIV prevention, there is a chance to correct for missed opportunities with oral PrEP rollout, understand client preferences and patterns of use, and ensure more effective coordination across geographies, populations, and projects. To facilitate this…

Research

Document